Back

Translational rodent models embracing the complex pathophysiology of heart failure with preserved ejection fraction

11 May 2024 (16:00 - 16:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - pathophysiology and mechanisms 12 Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Rana Assaly

Cardiomedex, Escalquens (France)

5 More presentations in this session

Presentation thumbnail
Implications of sarcopenia and obesity in patients across the spectrum of heart failure with preserved ejection fraction
Doctor P. Sagmeister (Leipzig, DE)
Abstract Slides Video
Presentation thumbnail
Similarities and differences between aortic stenosis with normal left ventricular systolic function and heart failure with preserved ejection fraction
Doctor N. De Biase (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
The Endothelial Activation and Stress Index (EASIX) in heart failure with preserved ejection fraction - getting to the bottom of endothelial dysfunction as a central paradigm in heart failure
Doctor V. Zach (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Perception of heart failure with preserved ejection fraction by experienced cardiologists in Belgium
Doctor C. Georges (BE)
Abstract Slides Video
Presentation thumbnail
Characteristics and outcomes of patients with heart failure with preserved ejection fraction referred to a nurse led community heart failure clinic
Miss S. Tavares (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - pathophysiology and mechanisms 12

The Event

Event poster

Heart Failure 2024

11 May 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
ACEI plus GLP1-RA or SGLT2i, as well as ARNI, exerted distinct protective effects against diabetic nephropathy and heart failure with preserved ejection fraction in eNOS-/- dbdb mice.
thumbnail
Congress Presentation
Empagliflozin improves diastolic function in obese ZSF1 rats by restoring the cardiac mitochondrial respiratory capacity.
thumbnail
Congress Presentation
Treatment of diastolic dysfunction by targeting beta-adrenergic receptors in vivo in a murine model of cardiometabolic HFpEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources